Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

High-Fidelity Simulation: An Application to Psychopharmacological Training for the Psychiatric Nurse Practitioner Student.

Abram MD, Forbes MO.

Issues Ment Health Nurs. 2019 Jan 14:1-8. doi: 10.1080/01612840.2018.1519621. [Epub ahead of print]

PMID:
30640555
2.

KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.

Socała K, Mogilski S, Pieróg M, Nieoczym D, Abram M, Szulczyk B, Lubelska A, Latacz G, Doboszewska U, Wlaź P, Kamiński K.

ACS Chem Neurosci. 2018 Oct 10. doi: 10.1021/acschemneuro.8b00476. [Epub ahead of print]

PMID:
30247871
3.

Evaluation of anticonvulsant and analgesic activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.

Rapacz A, Głuch-Lutwin M, Mordyl B, Filipek B, Abram M, Kamiński K.

Epilepsy Res. 2018 Jul;143:11-19. doi: 10.1016/j.eplepsyres.2018.03.024. Epub 2018 Mar 30.

PMID:
29631129
4.

Antimycobacterial potential of the juniper berry essential oil in tap water.

Peruč D, Gobin I, Abram M, Broznić D, Svalina T, Štifter S, Staver MM, Tićac B.

Arh Hig Rada Toksikol. 2018 Mar 1;69(1):46-54. doi: 10.2478/aiht-2018-69-3085.

PMID:
29604199
5.

The Role of the Registered Nurse Working in Substance Use Disorder Treatment: A Hermeneutic Study.

Abram MD.

Issues Ment Health Nurs. 2018 Jun;39(6):490-498. doi: 10.1080/01612840.2017.1413462. Epub 2018 Jan 25.

PMID:
29370552
6.

Molecular Mechanisms of Photoadaptation of Photosystem I Supercomplex from an Evolutionary Cyanobacterial/Algal Intermediate.

Haniewicz P, Abram M, Nosek L, Kirkpatrick J, El-Mohsnawy E, Olmos JDJ, Kouřil R, Kargul JM.

Plant Physiol. 2018 Feb;176(2):1433-1451. doi: 10.1104/pp.17.01022. Epub 2017 Nov 29.

7.

Multifunctional Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties.

Abram M, Zagaja M, Mogilski S, Andres-Mach M, Latacz G, Baś S, Łuszczki JJ, Kieć-Kononowicz K, Kamiński K.

J Med Chem. 2017 Oct 26;60(20):8565-8579. doi: 10.1021/acs.jmedchem.7b01114. Epub 2017 Oct 4.

PMID:
28934547
8.

Antiferromagnetism, charge density wave, and d-wave superconductivity in the extended t-J-U model: role of intersite Coulomb interaction and a critical overview of renormalized mean field theory.

Abram M, Zegrodnik M, Spałek J.

J Phys Condens Matter. 2017 Sep 13;29(36):365602. doi: 10.1088/1361-648X/aa7a21. Epub 2017 Jun 19.

PMID:
28627506
9.

Three New Lactobacillus plantarum Strains in the Probiotic Toolbox against Gut Pathogen Salmonella enterica Serotype Typhimurium.

Potočnjak M, Pušić P, Frece J, Abram M, Janković T, Gobin I.

Food Technol Biotechnol. 2017 Mar;55(1):48-54. doi: 10.17113/ftb.55.01.17.4693.

10.

Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.

Margot NA, Wong P, Kulkarni R, White K, Porter D, Abram ME, Callebaut C, Miller MD.

J Infect Dis. 2017 Mar 15;215(6):920-927. doi: 10.1093/infdis/jix015.

PMID:
28453836
11.

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial<sup/>.

Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS.

HIV Clin Trials. 2017 May;18(3):135-140. doi: 10.1080/15284336.2017.1291867. Epub 2017 Mar 17.

PMID:
28303753
12.

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.

Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):226-231. doi: 10.1097/QAI.0000000000001344.

13.

Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.

Abram ME, Ram RR, Margot NA, Barnes TL, White KL, Callebaut C, Miller MD.

PLoS One. 2017 Feb 17;12(2):e0172206. doi: 10.1371/journal.pone.0172206. eCollection 2017.

14.

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Post FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):180-184. doi: 10.1097/QAI.0000000000001186.

15.

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.

Gallant JE, Daar ES, Raffi F, Brinson C, Ruane P, DeJesus E, Johnson M, Clumeck N, Osiyemi O, Ward D, Morales-Ramirez J, Yan M, Abram ME, Plummer A, Cheng AK, Rhee MS.

Lancet HIV. 2016 Apr;3(4):e158-65. doi: 10.1016/S2352-3018(16)00024-2. Epub 2016 Mar 14.

PMID:
27036991
16.

New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.

Kamiński K, Zagaja M, Rapacz A, Łuszczki JJ, Andres-Mach M, Abram M, Obniska J.

Bioorg Med Chem. 2016 Feb 15;24(4):606-18. doi: 10.1016/j.bmc.2015.12.027. Epub 2015 Dec 18.

PMID:
26746343
17.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Pozniak A, Arribas JR, Gathe J, Gupta SK, Post FA, Bloch M, Avihingsanon A, Crofoot G, Benson P, Lichtenstein K, Ramgopal M, Chetchotisakd P, Custodio JM, Abram ME, Wei X, Cheng A, McCallister S, SenGupta D, Fordyce MW; GS-US-292-0112 Study Team.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):530-7. doi: 10.1097/QAI.0000000000000908.

18.

Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results.

Gallant JE, Koenig E, Andrade-Villanueva JF, Chetchotisakd P, DeJesus E, Antunes F, Arastéh K, Rizzardini G, Fehr J, Liu HC, Abram ME, Cao H, Szwarcberg J.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):338-40. doi: 10.1097/QAI.0000000000000598.

19.

Intermittent theta burst stimulation over left BA10 enhances virtual reality-based prospective memory in healthy aged subjects.

Debarnot U, Crépon B, Orriols E, Abram M, Charron S, Lion S, Roca P, Oppenheim C, Gueguen B, Ergis AM, Baron JC, Piolino P.

Neurobiol Aging. 2015 Aug;36(8):2360-9. doi: 10.1016/j.neurobiolaging.2015.05.001. Epub 2015 May 9.

PMID:
26058839
20.

Virulence genes and cytokine profile in systemic murine Campylobacter coli infection.

Klančnik A, Pogačar MŠ, Raspor P, Abram M, Možina SS, Vučković D.

Virulence. 2015;6(6):581-90. doi: 10.1080/21505594.2015.1042642. Epub 2015 Jun 3.

21.

AtEAF1 is a potential platform protein for Arabidopsis NuA4 acetyltransferase complex.

Bieluszewski T, Galganski L, Sura W, Bieluszewska A, Abram M, Ludwikow A, Ziolkowski PA, Sadowski J.

BMC Plant Biol. 2015 Mar 5;15:75. doi: 10.1186/s12870-015-0461-1.

22.

Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.

Bubonja-Sonje M, Matovina M, Skrobonja I, Bedenic B, Abram M.

Microb Drug Resist. 2015 Jun;21(3):261-9. doi: 10.1089/mdr.2014.0172. Epub 2015 Jan 7.

PMID:
25565041
23.

Baseline antiretroviral resistance mutations and treatment-emergent resistance in HIV-1 RNA-suppressed patients switching to EVG/COBI/FTC/TDF or continuing on their PI-, NNRTI-, or RAL-based regimen.

Andreatta K, Kulkarni R, Abram ME, Nguyen T, Cao H, Miller MD, White KL.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):519-26. doi: 10.1097/QAI.0000000000000503.

PMID:
25559592
24.

Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment.

Post FA, Winston J, Andrade-Villanueva JF, Fisher M, Liu Y, Beraud C, Abram ME, Graham H, Rhee MS, Cheng AK, Szwarcberg J; Study 118 Team.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):310-3. doi: 10.1097/QAI.0000000000000476.

PMID:
25469527
25.

Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairment.

McDonald CK, Martorell C, Ramgopal M, Laplante F, Fisher M, Post FA, Liu Y, Curley J, Abram ME, Custodio J, Graham H, Rhee MS, Szwarcberg J.

HIV Clin Trials. 2014 Nov-Dec;15(6):269-73. doi: 10.1310/hct1506-269.

PMID:
25433666
26.

A cell-based strategy to assess intrinsic inhibition efficiencies of HIV-1 reverse transcriptase inhibitors.

Abram ME, Tsiang M, White KL, Callebaut C, Miller MD.

Antimicrob Agents Chemother. 2015 Feb;59(2):838-48. doi: 10.1128/AAC.04163-14. Epub 2014 Nov 17.

27.

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients.

Kulkarni R, Abram ME, McColl DJ, Barnes T, Fordyce MW, Szwarcberg J, Cheng AK, Miller MD, White KL.

HIV Clin Trials. 2014 Sep-Oct;15(5):218-30. doi: 10.1310/hct1505-218.

PMID:
25350960
28.

Stress response and virulence of heat-stressed Campylobacter jejuni.

Klančnik A, Vučković D, Jamnik P, Abram M, Možina SS.

Microbes Environ. 2014;29(4):338-45. doi: 10.1264/jsme2.ME14020. Epub 2014 Oct 2.

29.

Mechanisms of remembering the past and imagining the future--new data from autobiographical memory tasks in a lifespan approach.

Abram M, Picard L, Navarro B, Piolino P.

Conscious Cogn. 2014 Oct;29:76-89. doi: 10.1016/j.concog.2014.07.011. Epub 2014 Aug 13.

PMID:
25139201
30.

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

Guzvinec M, Izdebski R, Butic I, Jelic M, Abram M, Koscak I, Baraniak A, Hryniewicz W, Gniadkowski M, Tambic Andrasevic A.

Antimicrob Agents Chemother. 2014 Oct;58(10):6277-83. doi: 10.1128/AAC.03116-14. Epub 2014 Jul 28.

31.

Model of hard spheroplatelets near a hard wall.

Kapanowski A, Abram M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jun;89(6):062503. Epub 2014 Jun 10.

PMID:
25019801
32.

Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Abram ME, Ferris AL, Das K, Quinoñes O, Shao W, Tuske S, Alvord WG, Arnold E, Hughes SH.

J Virol. 2014 Jul;88(13):7589-601. doi: 10.1128/JVI.00302-14. Epub 2014 Apr 23.

33.

Plasma cells in immunopathology: concepts and therapeutic strategies.

Tiburzy B, Kulkarni U, Hauser AE, Abram M, Manz RA.

Semin Immunopathol. 2014 May;36(3):277-88. doi: 10.1007/s00281-014-0426-8. Epub 2014 Apr 17. Review.

PMID:
24740168
34.

Dirofilaria repens infection in a ten-year-old boy from the Istria Peninsula: case report.

Glavan N, Pećanić S, Bosak A, Gacanin L, Abram M, Jonjić N.

Acta Clin Croat. 2013 Dec;52(4):533-6.

PMID:
24697007
35.

Salmonella enterica arthritis in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapy.

Bubonja-Sonje M, Rubinic D, Anic F, Novak S, Vuckovic D, Abram M.

West Indian Med J. 2013 Mar;62(3):270-2.

PMID:
24564054
36.

Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.

Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann MM, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16550-5. doi: 10.1073/pnas.1310215110. Epub 2013 Sep 19.

37.

Epidemiology of oral squamous cell carcinoma.

Abram MH, van Heerden WF, Rheeder P, Girdler-Brown BV, van Zyl AW.

SADJ. 2012 Nov;67(10):550-3.

PMID:
23957093
38.

Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival.

Gabler J, Wittmann J, Porstner M, Renz H, Jäck HM, Abram M, Zemlin M.

Eur J Immunol. 2013 Nov;43(11):3028-37. doi: 10.1002/eji.201243271. Epub 2013 Aug 29.

39.

In vivo modulation of Campylobacter jejuni virulence in response to environmental stress.

Klančnik A, Vučković D, Plankl M, Abram M, Smole Možina S.

Foodborne Pathog Dis. 2013 Jun;10(6):566-72. doi: 10.1089/fpd.2012.1298. Epub 2013 May 2.

PMID:
23638846
40.

Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness.

Abram ME, Hluhanich RM, Goodman DD, Andreatta KN, Margot NA, Ye L, Niedziela-Majka A, Barnes TL, Novikov N, Chen X, Svarovskaia ES, McColl DJ, White KL, Miller MD.

Antimicrob Agents Chemother. 2013 Jun;57(6):2654-63. doi: 10.1128/AAC.02568-12. Epub 2013 Mar 25.

41.

A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.

Rockstroh JK, DeJesus E, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Plummer A, Abram M, Cheng AK, Fordyce MW, Szwarcberg J; GS-236-0103 Study Team.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):483-6. doi: 10.1097/QAI.0b013e318286415c.

PMID:
23337366
42.

Functional independence within the self-memory system: new insights from two cases of developmental amnesia.

Picard L, Mayor-Dubois C, Maeder P, Kalenzaga S, Abram M, Duval C, Eustache F, Roulet-Perez E, Piolino P.

Cortex. 2013 Jun;49(6):1463-81. doi: 10.1016/j.cortex.2012.10.003. Epub 2012 Nov 20.

PMID:
23261550
43.

Listeriosis in pregnancy: case report and retrospective study.

Bubonja-Sonje M, Mustac E, Brunn A, Deckert M, Abram M.

J Matern Fetal Neonatal Med. 2013 Feb;26(3):321-3. doi: 10.3109/14767058.2012.733780. Epub 2012 Oct 29.

PMID:
23039339
44.

Internal contamination by actinides after wounding: a robust rodent model for assessment of local and distant actinide retention.

Griffiths NM, Wilk JC, Abram MC, Renault D, Chau Q, Helfer N, Guichet C, Van der Meeren A.

Health Phys. 2012 Aug;103(2):187-94. doi: 10.1097/HP.0b013e31825aa202.

PMID:
22951478
45.

[What about the mental time travel and age-related effects?].

Coste C, Navarro B, Abram M, Duval C, Picard L, Piolino P.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Mar;10(1):95-105. doi: 10.1684/pnv.2012.0328. French.

PMID:
22414404
46.

Epidemiologic characteristics of human campylobacteriosis in the County Primorsko-goranska (Croatia), 2003-2007.

Vucković D, Gregorović-Kesovija P, Brumini G, Tićac B, Abram M.

Coll Antropol. 2011 Sep;35(3):847-53.

PMID:
22053566
47.

Breast abscess in a man due to Salmonella enterica serotype Enteritidis.

Brncic N, Gorup L, Strcic M, Abram M, Mustac E.

J Clin Microbiol. 2012 Jan;50(1):192-3. doi: 10.1128/JCM.05361-11. Epub 2011 Oct 26.

48.

In vitro oxidative stress induced by conventional and self-ligating brackets.

Buljan ZI, Ribaric SP, Abram M, Ivankovic A, Spalj S.

Angle Orthod. 2012 Mar;82(2):340-5. doi: 10.2319/061811-395.1. Epub 2011 Sep 13.

PMID:
21913853
49.

Endogenous gas gangrene after laparoscopic cholecystectomy.

Zelić M, Kunisek L, Mendrila D, Gudelj M, Abram M, Uravić M.

West Indian Med J. 2011 Jan;60(1):96-8.

PMID:
21809721
50.

Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.

Grémy O, Tsapis N, Chau Q, Renault D, Abram MC, Van der Meeren A.

Radiat Res. 2010 Nov;174(5):637-44. doi: 10.1667/RR2203.1. Epub 2010 Jul 14.

PMID:
20726717

Supplemental Content

Support Center